BioSilta Release: EnPresso(R) Yeast Defined Tablet Enhances Protein Production Using EnBase(R) Technology

OULU, Finland--(BUSINESS WIRE)--BioSilta announces the release of the EnPresso® Y Defined Tablet medium designed for protein production in yeast, such as Pichia pastoris. The EnPresso Y Defined is a pre-sterilized tablet based on the patented EnBase® technology. The EnBase technology is based on providing an enzymatic-controlled glucose supply in a fed-batch type manner, which allows an extended growth period and promotes higher final cell density. This methodology regulates the growth of the microbe without oxygen limitation and facilitates more efficient protein production in recombinant protein expression. In addition, EnBase technology is an invaluable tool in bioprocess scale-up, protein production and optimization, enzyme screening, protein crystallography, plasmid production and brewery contaminant detection.